International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

被引:5294
作者
Miyakis, S
Lockshin, MD
Atsumi, T
Branch, DW
Brey, RL
Cervera, R
Derksen, RHWM
De Groot, PG
Koike, T
Meroni, PL
Reber, G
Shoenfeld, Y
Tincani, A
Vlachoyiannopoulos, PG
Krilis, SA
机构
[1] Univ New S Wales, St George Hosp, Sydney, NSW, Australia
[2] Hosp Special Surg, Cornell Med Ctr, New York, NY 10021 USA
[3] Hokkaido Univ, Sapporo, Hokkaido, Japan
[4] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA
[5] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78285 USA
[6] Hosp Clin Barcelona, Barcelona, Spain
[7] Univ Utrecht, Med Ctr, Utrecht, Netherlands
[8] Univ Milan, Ist Auxol Italiano, Milan, Italy
[9] Univ Hosp, Geneva, Switzerland
[10] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
[11] Tel Aviv Univ, IL-69978 Tel Aviv, Israel
[12] Univ Brescia, Spedali Civili, I-25121 Brescia, Italy
[13] Univ Athens, Dept Pathophysiol, GR-10679 Athens, Greece
关键词
anticardiolipin; antiphospolipid syndrome; beta(2) glycoprotein-I; classification criteria; lupus anticoagulant; thrombosis;
D O I
10.1111/j.1538-7836.2006.01753.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
New clinical, laboratory and experimental insights, since the 1999 publication of the Sapporo preliminary classification criteria for antiphospholipid syndrome (APS), had been addressed at a workshop in Sydney, Australia, before the Eleventh International Congress on antiphospholipid antibodies. In this document, we appraise the existing evidence on clinical and laboratory features of APS addressed during the forum. Based on this, we propose amendments to the Sapporo criteria. We also provide definitions on features of APS that were not included in the updated criteria.
引用
收藏
页码:295 / 306
页数:12
相关论文
共 142 条
[1]  
*ACOG, 2002, ACOG PRACT B, V33
[2]  
AMIGO MC, 1992, J RHEUMATOL, V19, P1181
[3]  
[Anonymous], 1991, J Clin Pathol, V44, P885
[4]  
[Anonymous], 1994, NOMENCLATURE CRITERI, V9th, P253
[5]  
Arnout J, 1999, THROMB HAEMOSTASIS, V81, P929
[6]  
Arnout J, 1996, THROMB HAEMOSTASIS, V75, P536
[7]   Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines [J].
Asherson, RA ;
Cervera, R ;
de Groot, PG ;
Erkan, D ;
Boffa, MC ;
Piette, JC ;
Khamashta, MA ;
Shoenfeld, Y .
LUPUS, 2003, 12 (07) :530-534
[8]  
Atsumi T, 2000, ARTHRITIS RHEUM-US, V43, P1982, DOI 10.1002/1529-0131(200009)43:9<1982::AID-ANR9>3.0.CO
[9]  
2-2
[10]   Value of autoantibodies to β2-glycoprotein 1 in the diagnosis of antiphospholipid syndrome [J].
Audrain, MAP ;
El Kouri, D ;
Hamidou, MA ;
Mioche, L ;
Ibara, A ;
Langlois, ML ;
Muller, JY .
RHEUMATOLOGY, 2002, 41 (05) :550-553